About Zynerba Pharmaceuticals, Inc. (adapted from Zynerba Pharmaceuticals, Inc. prospectus):
They are a ten-year-old specialty pharmaceutical company focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.